Rchr
J-GLOBAL ID：200901034255338412
Update date: Apr. 19, 2024
Matsuo Kazuhiro
マツオ カズヒロ | Matsuo Kazuhiro
Affiliation and department：
Research field (3)：
Immunology
, Bacteriology
, Molecular biology
Research keywords (4)：
結核
, エイズ
, ワクチン
, 免疫
Research theme for competitive and other funds (4)：
- 2018 - 2021 Evaluation of protective immune responses by recombinant BCG/vaccinia prime-boost AIDS vaccine in macaque model of SIV infection
- 2012 - 2014 Development of vaccine against Mycobacterium tuberculosis by intranasal immunization with replication-deficient recombinant human parainfluenza type 2 virus-Ag85B in mice.
- 2010 - 2011 Development of novel vaccine against tuberculosis using recombinant BCG expressing SOCS1 antagonist
- 組換えBCGを利用した新規ワクチン開発
Papers (24)：
-
Shihoko Komine-Aizawa, Satoru Mizuno, Akira Kawano, Satoshi Hayakawa, Kazuhiro Matsuo, Mitsuo Honda. The Induction of Antigen 85B-Specific CD8+ T Cells by Recombinant BCG Protects against Mycobacterial Infection in Mice. International journal of molecular sciences. 2023. 24. 2
-
Satoru Mizuno, Yasushi Chuma, Yukihiro Shibuya, Shigeo Horibata, Tomoe Baba, Emi Yokokawa, Kazuhiro Matsuo. Culture filtrate proteins from BCG act as adjuvants for cytotoxic T lymphocyte induction. Frontiers in Immunology. 2023. 14
-
Naoya Nishimura, Noriyuki Tomiyasu, Shota Torigoe, Satoru Mizuno, Hanako Fukano, Eri Ishikawa, Harutaka Katano, Yoshihiko Hoshino, Kazuhiro Matsuo, Masatomo Takahashi, et al. Mycobacterial mycolic acids trigger inhibitory receptor Clec12A to suppress host immune responses. Tuberculosis (Edinburgh, Scotland). 2023. 138. 102294-102294
-
Shihoko Komine-Aizawa, Satoru Mizuno, Kazuhiro Matsuo, Takahiro Namiki, Satoshi Hayakawa, Mitsuo Honda. Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii. Vaccines. 2021. 9. 11
-
Tomotaka Okamura, Yuya Shimizu, Masamitsu N Asaka, Tomohiro Kanuma, Yusuke Tsujimura, Takuya Yamamoto, Kazuhiro Matsuo, Yasuhiro Yasutomi. Long-term protective immunity induced by an adjuvant-containing live-attenuated AIDS virus. NPJ vaccines. 2021. 6. 1. 124-124
ｍore...
MISC (42)：
-
佐藤洋隆, 陳晶, 張険峰, 松尾和浩, 志田壽利. SIV-gag rBCGプライムワクシニアm8Δブーストにおけるワクシニアプロモーターの検討. 日本ウイルス学会学術集会プログラム・抄録集. 2012. 60th
-
M. Kanekiyo, Y. Ami, K. Matsuo, K. Someya, N. Yamamoto, M. Honda. Low Dose Immunization of Codon-Optimized Recombinant BCG Confers Long-Lasting SIV-Specific Memory T Cells After Recombinant Vaccinia Boost in Macaques. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2011. 27. 10. A96-A96
-
Kazuhiro Matsuo, Naoki Yamamoto. Paradigm change in immune correlation: cellular or humoral?. EXPERT REVIEW OF VACCINES. 2010. 9. 9. 985-987
-
Mitsuo Honda, Rui Wang, Wing-Pui Kong, Masaru Kanekiyo, Wataru Akahata, Ling Xu, Kazuhiro Matsuo, Kannan Natarajan, Howard Robinson, Tedi E. Asher, et al. Different Vaccine Vectors Delivering the Same Antigen Elicit CD8(+) T Cell Responses with Distinct Clonotype and Epitope Specificity. JOURNAL OF IMMUNOLOGY. 2009. 183. 4. 2425-2434
-
Hajime Suzuki, Minoru Kidokoro, Ismael Ben Fofana, Takashi Ohashi, Tomotaka Okamura, Kazuhiro Matsuo, Naoki Yamamoto, Hisatoshi Shida. Immunogenicity of newly constructed attenuated vaccinia strain LC16m8Δ that expresses SIV Gag protein. Vaccine. 2009. 27. 7. 966-971
ｍore...
Books (1)：
-
やさしく学ぶ免疫システム-インフルエンザ、アレルギー、エイズと闘うメカニズム
ソフトバンククリエイティブ 2007
Education (3)：
- 1990 - Nagoya University Graduate School of Engineering
- 1980 - 1982 Nagoya University Graduate School of Engineering
- 1976 - 1980 Nagoya University School of Engineering
Work history (6)：
Return to Previous Page
